Hansa Medical AB (CE) (HNSBF)
USOTC
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current HNSBF market cap is 158.02M. The company's latest EPS is SEK -15.3163 and P/E is -0.20.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 6.1M | 33.88M | 154.53M | 134.09M | 171.32M |
| Operating Income | -425.08M | -539.58M | -576.12M | -791.16M | -637.37M |
| Net Income | -420.85M | -548.28M | -611.13M | -831.72M | -806.74M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 1.43B | 1.01B | 1.69B | 1.02B | 800.64M |
| Total Liabilities | 192.37M | 255.24M | 1.08B | 1.19B | 1.39B |
| Total Equity | 1.24B | 757.57M | 602.91M | -167.88M | -589.32M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -290.27M | -481.17M | -502.73M | -755.66M | -733.92M |
| Investing | 182.53M | -2.4M | 229.31M | -284k | -116k |
| Financing | 1.07B | -4.86M | 1.12B | -7.55M | 405.84M |
| Market Cap | 158.02M |
| Price to Earnings Ratio | -0.20 |
| Price to Sales Ratio | 0.92 |
| Price to Cash Ratio | 0.39 |
| Price to Book Ratio | -0.27 |
| Dividend Yield | - |
| Shares Outstanding | 52.67M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 2.39% |
| 52 Week High | 3.65 |
| 52 Week Low | 2.83 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Hansa Medical AB (CE) |
| Address |
scheelevagen 22 lund 223 63 |
| Website | https://www.hansabiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
